The application of radionuclide antisense therapy for malignant tumours.
Zheng
J
J
Tan
T
T
D015195:Drug Design; D004355:Drug Stability; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000235:genetics; D020319:Oligodeoxyribonucleotides, Antisense; D009857:Oncogenes; D012333:RNA, Messenger / Q000235:genetics; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics* / Q000627:therapeutic use
D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D019275:Radiopharmaceuticals